NSE · ZYDUSLIFE.NS
Zydus Lifesciences Limited
₹1,241.40+₹57.00 (+4.81%)
Zydus Lifesciences Limited’s quoted price sits in the upper half of its reported 52-week range, 0.59% below the high.
Loading market information…
NSE · FDC.NS · INR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:18 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
FDC Limited’s quoted price sits in the lower half of its reported 52-week range, 19.99% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
FDC Limited’s forward annual dividend is ₹2.25 per share, paid annual. The forward yield is 0.59% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
FDC Limited’s next earnings report is currently expected on Jan 28, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow FDC Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
FDC Limited, together with its subsidiaries, manufactures and trades in pharmaceutical products in India, the United States, and internationally. The company offers pharmaceutical formulations for various therapeutic segments, including anti-infectives, gastrointestinal, ophthalmology, vitamins, minerals, dietary supplements, cardiovascular and anti-diabetic therapies, respiratory care, gynaecology, dermatology, and analgesics in the form of tablets, capsules, oral liquids, ophthalmic drops, topical preparations, and paediatric-friendly solutions. It also provides functional food, such as flavoured ORS powders, ready-to-drink electrolyte beverages, vitamin-enriched supplements, antioxidant blends and protein-fortified drinks; and various active pharmaceutical ingredients. The company sells its products under the Zifi, Zefu, Zocon, Amodep-AT, Zathrin, Vitcofol, Ziglim, Ziglim-M,Mycoderm, Zoxan, Cotaryl, Pyrimon DF, Zipod, Electral, and Enerzal brands. It also exports its products to approximately 50 countries. FDC Limited was founded in 1936 and is based in Mumbai, India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:18 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q3 2025 | Feb 12, 2025 | ₹2.28 | ₹4.64B-2.62% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹1,241.40+₹57.00 (+4.81%)
Zydus Lifesciences Limited’s quoted price sits in the upper half of its reported 52-week range, 0.59% below the high.
₹1,357.60+₹12.60 (+0.94%)
Dr. Reddy's Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 4.05% below the high.
₹1,373.50+₹15.50 (+1.14%)
Cipla Limited’s quoted price sits in the lower half of its reported 52-week range, 13.8% below the high.
₹5,107.00+₹28.00 (+0.55%)
Alkem Laboratories Limited’s quoted price sits in the lower half of its reported 52-week range, 13.93% below the high.
₹845.25+₹7.90 (+0.94%)
Granules India Limited’s quoted price sits in the upper half of its reported 52-week range, 8.49% below the high.
₹794.00-₹0.85 (-0.11%)
Alembic Pharmaceuticals Limited’s quoted price sits in the lower half of its reported 52-week range, 20.44% below the high.
₹207.25-₹2.25 (-1.07%)
Indoco Remedies Limited’s quoted price sits in the lower half of its reported 52-week range, 28.04% below the high.
₹511.00+₹1.10 (+0.22%)
Lincoln Pharmaceuticals Limited’s quoted price sits in the lower half of its reported 52-week range, 33.64% below the high.
